Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALL vs GSK✓SelectedUSD · GSKALL vs GSK performance historyLatest closeAs of0.00%11/17
Stock and ETF performance explorer

ALL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+31.8%
GSK return
+7.1%
Excess return
+24.6%
Maximum drawdown
-19.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D0.0%-2.3%+2.3%+0.6%
7D+3.6%-3.0%+6.6%+4.4%
30D+9.1%+0.4%+8.7%+8.9%
3M+5.2%-1.2%+6.4%+5.4%
6M+25.6%+0.9%+24.7%+25.1%
YTD+31.8%+4.0%+27.8%+29.4%
1Y+31.8%+7.3%+24.5%+28.1%
All+31.8%+7.1%+24.6%+28.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling